Invesco Ltd. Cuts Stock Holdings in Genpact Limited (NYSE:G)

Invesco Ltd. decreased its stake in shares of Genpact Limited (NYSE:G - Free Report) by 84.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 279,197 shares of the business services provider's stock after selling 1,497,514 shares during the quarter. Invesco Ltd. owned approximately 0.16% of Genpact worth $11,992,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. SRH Advisors LLC purchased a new position in shares of Genpact in the 4th quarter valued at $26,000. Atlas Capital Advisors Inc. grew its position in Genpact by 55.8% during the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after purchasing an additional 216 shares during the period. Manchester Capital Management LLC purchased a new position in shares of Genpact during the 4th quarter valued at about $38,000. Smartleaf Asset Management LLC lifted its holdings in shares of Genpact by 416.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock valued at $41,000 after buying an additional 783 shares during the period. Finally, UMB Bank n.a. grew its holdings in Genpact by 55.7% during the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock worth $52,000 after acquiring an additional 433 shares during the period. 96.03% of the stock is owned by hedge funds and other institutional investors.

Genpact Price Performance

Genpact stock traded up $0.25 during midday trading on Friday, reaching $48.07. The company had a trading volume of 1,003,927 shares, compared to its average volume of 1,335,176. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. The firm's fifty day simple moving average is $49.76 and its 200-day simple moving average is $46.32. The company has a market capitalization of $8.44 billion, a P/E ratio of 16.93, a P/E/G ratio of 1.84 and a beta of 1.06. Genpact Limited has a 12-month low of $30.38 and a 12-month high of $56.76.

Genpact (NYSE:G - Get Free Report) last announced its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. As a group, equities analysts anticipate that Genpact Limited will post 3.21 EPS for the current year.

Genpact Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were paid a $0.17 dividend. The ex-dividend date was Tuesday, March 11th. This is an increase from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.41%. Genpact's dividend payout ratio (DPR) is 23.94%.

Insider Activity

In related news, CEO Balkrishan Kalra sold 13,600 shares of the business's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the sale, the chief executive officer now owns 310,246 shares in the company, valued at approximately $15,167,926.94. The trade was a 4.20 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 2.80% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have commented on the company. Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and upped their price objective for the stock from $44.00 to $55.00 in a research report on Tuesday, January 21st. Needham & Company LLC raised their price target on shares of Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a research report on Friday, February 7th. TD Cowen upgraded shares of Genpact from a "hold" rating to a "buy" rating and upped their price objective for the stock from $45.00 to $60.00 in a research report on Friday, February 7th. Finally, Mizuho increased their target price on shares of Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research note on Monday, February 10th. Five investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $50.38.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.